A randomized trial comparing CEF to CME in premenopausal women with node positive breast cancer: update of NCICCTG MA.5.

被引：0
|
作者：
Levine, MN
Pritchard, KI
Bramwell, VHC
Shepherd, LE
Tu, D
Paul, N
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Western Ontario, London, ON, Canada
[4] Queens Univ, Kingston, ON, Canada
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [1] Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).
    O'Malley, F. P.
    Chia, S.
    Tu, D.
    Shepherd, L. E.
    Levine, M. N.
    Huntsman, D. G.
    Bramwell, V. H.
    Andrulis, I. L.
    Pritchard, K. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 11S - 11S
  • [2] Topoisomerase II alpha protein overexpression has predictive utility in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).
    O'Malley, F. P.
    Chia, S.
    Tu, D.
    Shepherd, L. E.
    Levine, M. N.
    Huntsman, D.
    Bramwell, V. H.
    Andrulis, I
    Pritchard, K., I
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S18 - S18
  • [3] Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
    Levine, MN
    Pritchard, KL
    Bramwell, VHC
    Shepherd, LE
    Tu, DS
    Paul, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5166 - 5170
  • [4] A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCICCTG MA. 21: Results of an interim analysis
    Burnell, M.
    Levine, M.
    Chapman, J. A.
    Bramwell, V
    Gelmon, K.
    Walley, B.
    Whelan, T.
    Albain, K.
    Perez, E.
    Rugo, H.
    Ding, Z.
    O'Brien, P.
    Shepherd, L.
    Pritchard, K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (01) : 117 - 117
  • [5] Anthracyclines in basal breast cancer: The NCIC-CTG trial MA5 comparing adjuvant CMF to CEF
    Cheang, M.
    Chia, S. K.
    Tu, D.
    Jiang, S.
    Shepherd, L. E.
    Pritchard, K. I.
    Nielsen, T. O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] RANDOMIZED TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN TO CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, PREDNISONE ADJUVANT THERAPY IN PREMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER
    INGLE, JN
    EVERSON, LK
    WIEAND, HS
    CULLINAN, SA
    WOLD, LE
    HAGEN, JB
    MARTIN, JK
    KROOK, JE
    FITZGIBBONS, RG
    FOLEY, JF
    AHMANN, DL
    PFEIFLE, DM
    GREEN, SJ
    [J]. CANCER, 1989, 63 (07) : 1257 - 1264
  • [7] QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL, RANDOMIZED TRIAL COMPARING ZOLADEX WITH CMF IN PREMENOPAUSAL, NODE-POSITIVE BREAST-CANCER PATIENTS
    DEHAES, JCJM
    OLSCHEWSK, M
    JONAT, W
    KAUFMANN, M
    SCHUMACHER, M
    KOLVENBAG, G
    [J]. QUALITY OF LIFE RESEARCH, 1994, 3 (01) : 73 - 74
  • [8] Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
    Ragaz, J
    Jackson, SM
    Le, N
    Plenderleith, IH
    Spinelli, JJ
    Basco, VE
    Wilson, KS
    Knowling, MA
    Coppin, CML
    Paradis, M
    Coldman, AJ
    Olivotto, IA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14): : 956 - 962
  • [9] Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer
    Levine, MN
    Bramwell, VH
    Pritchard, KI
    Norris, BD
    Shepherd, LE
    Abu-Zahra, H
    Findlay, B
    Warr, D
    Bowman, D
    Myles, J
    Arnold, A
    Vandenberg, T
    MacKenzie, R
    Robert, J
    Ottaway, J
    Burnell, M
    Williams, CK
    Tu, DS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2651 - 2658
  • [10] ADJUVANT TAMOXIFEN FOR PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR POSITIVE, NODE-POSITIVE BREAST-CANCER - A RANDOMIZED STUDY
    GUNDERSEN, S
    HANNISDAL, E
    SOREIDE, JA
    SKARSTEIN, A
    VARHAUG, JE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (01) : 49 - 53
12345